BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors (Q34476951)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors |
scientific article |
Statements
1 reference
BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors (English)
1 reference
David D Gibbs
1 reference
Davinder S Theti
1 reference
Nadya Wood
1 reference
Matthew Green
1 reference
Florence Raynaud
1 reference
Melanie Valenti
1 reference
Martin D Forster
1 reference
Fraser Mitchell
1 reference
Vassilios Bavetsias
1 reference
Elisa Henderson
1 reference
Ann L Jackman
1 reference
1 December 2005
1 reference
1 reference
65
1 reference
24
1 reference
11721-11728
1 reference
Identifiers
1 reference
1 reference